Sex differences in risk factors for interstitial cystitis/painful bladder syndrome in patients with lower urinary tract symptoms in China

被引:1
作者
He, Qun [1 ]
Yang, Yong [2 ]
Xia, Ming [1 ]
Li, Gui-Zhong [3 ]
Zhang, Ning [4 ]
Wu, Shi-Liang [5 ]
Jin, Rui [6 ]
Shen, Hong [7 ]
机构
[1] Beijing Shijitan Hosp, Dept Urol, Beijing, Peoples R China
[2] Beijing Canc Hosp, Beijing, Peoples R China
[3] Beijing Jishuitan Hosp, Beijing, Peoples R China
[4] Beijing ChaoYang Hosp, Beijing, Peoples R China
[5] Peking Univ, Hosp 1, Beijing 100871, Peoples R China
[6] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China
[7] Huaxi Hosp, Changsha, Hunan, Peoples R China
关键词
interstitial cystitis; painful bladder syndrome; questionnaire; risk factor;
D O I
10.1111/1744-1633.12113
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aim: The aim of the present study was to identify sex differences of risk factors for interstitial cystitis (IC)/painful bladder syndrome (PBS) in patients with lower urinary tract symptoms (LUTS) without urinary tract infection or benign prostate hyperplasia in China. Patients and Methods: A total of 954 outpatients with LUTS presenting for care to urology clinics in many hospitals on a national scale were surveyed using a standardized questionnaire. The definitions for PBS, based on the O'Leary-Sant IC symptom and problem indices, was used. The prevalence of possible risk factors was analysed using the Fisher's exact test, Pearson's chi(2)-test and binary logistic regression methods. Results: Of the multicentre patients surveyed (491 women and 463 men), 44.7 per cent (427/954) met the criteria for PBS. There was a significant difference between women and men [51.7 per cent (254/491) vs 37.3 per cent (173/463), P > 0.05]. After adjusting for confounding factors, bladder pain was found to be significantly associated with the consumption of stimulatory foods [odds ratio (OR): 3.85, 95 per cent confidence interval (CI): 1.58-9.36, P = 0.003] and anorectal disease (OR: 2.76, 95 per cent CI: 1.09-7.04, P = 0.03) in women. Caffeine beverage intake (OR: 3.54, 95 per cent CI: 1.54-8.12, P = 0.003) was identified the only modifiable association noted in a multivariate analysis of men. Factors in men significantly associated with an increased risk of IC/PBS were the consumption of caffeinated beverages (OR: 1.43, 95 per cent CI: 1.16-1.75, P = 0.001) and holding in urine (OR: 1.18, 95 per cent CI: 1.03-1.36, P = 0.034). Conclusions: A higher incidence of IC was founded in LUTS outpatients without urinary tract infection or benign prostate hyperplasia in China. Stimulating foods, irritable bowel, gynaecologically-infected diseases and anorectal disease are potential risk factors for IC/PBS in women. Caffeinated beverages and holding in urine are potential risk factors for IC/PBS in men.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 50 条
  • [21] INTRAVESICAL BUPIVACAINE FOR LIDOCAINE-REFRACTORY PATIENTS WITH PAINFUL BLADDER SYNDROME/INTERSTITIAL CYSTITIS
    Quillin, Renee
    Hooper, Gwen
    Erickson, Deborah
    NEUROUROLOGY AND URODYNAMICS, 2010, 29 (02) : 299 - 300
  • [22] Factors affecting the symptom-free period after hydrodistention in females with interstitial cystitis and painful bladder syndrome
    Kim, Hyeon Woo
    Lee, Jeong Zoo
    Shin, Dong Gil
    JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2019, 94 (3-4) : 329 - 333
  • [23] Impaired Na+/K+-ATPase Function in Patients with Interstitial Cystitis/Painful Bladder Syndrome
    Lee, Jane-Dar
    Yang, Wen-Kai
    Lee, Ming-Huei
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2016, 31 (02) : 280 - 285
  • [24] Decreased nanobacteria levels and symptoms of nanobacteria-associated interstitial cystitis/painful bladder syndrome after tetracycline treatment
    Qing-hua Zhang
    Xue-cheng Shen
    Zhan-song Zhou
    Zhi-wen Chen
    Gen-sheng Lu
    Bo Song
    International Urogynecology Journal, 2010, 21 : 103 - 109
  • [25] Factors affecting the symptom-free period after hydrodistention in females with interstitial cystitis and painful bladder syndrome
    Hyeon Woo Kim
    Jeong Zoo Lee
    Dong Gil Shin
    Journal of Inclusion Phenomena and Macrocyclic Chemistry, 2019, 94 : 329 - 333
  • [26] Decreased nanobacteria levels and symptoms of nanobacteria-associated interstitial cystitis/painful bladder syndrome after tetracycline treatment
    Zhang, Qing-hua
    Shen, Xue-cheng
    Zhou, Zhan-song
    Chen, Zhi-wen
    Lu, Gen-sheng
    Song, Bo
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2010, 21 (01) : 103 - 109
  • [27] The relationship between illness perception and worsening of interstitial cystitis/painful bladder syndrome symptoms: A cross-sectional study
    Garba, Kamaluddeen
    Avery, Miriam
    Yusuh, Muhammadbukhoree
    Abdelwahab, Omar
    Harris, Scott
    Birch, Brian R.
    Lwaleed, Bashir A.
    NEUROUROLOGY AND URODYNAMICS, 2021, 40 (08) : 2020 - 2025
  • [28] Pathophysiology, assessment, and treatment of overactive bladder symptoms in patients with interstitial cystitis/bladder pain syndrome
    Dobberfuhl, Amy D.
    NEUROUROLOGY AND URODYNAMICS, 2022, 41 (08) : 1958 - 1966
  • [29] Efficacy of Amitriptyline in Treatment-Naïve Patients with Interstitial Cystitis/Painful Bladder Syndrome
    Pontari M.
    Current Bladder Dysfunction Reports, 2010, 5 (4) : 175 - 176
  • [30] Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome
    Nickel, J. Curtis
    Moldwin, Robert
    Lee, Soledad
    Davis, Edward L.
    Henry, Richard A.
    Wyllie, Michael G.
    BJU INTERNATIONAL, 2009, 103 (07) : 910 - 918